Marinomed Biotech
€13.6
0
+€0.1+0.74% Tuesday 13:11
Statistics
Day High
13.6
Day Low
13.6
52W High
21.2
52W Low
12.25
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
19MarExpected
Expected EPS
N/A
Actual EPS
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow 93Z.MU. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Marinomed Biotech AG, a biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally. It operates through Virology, Immunology, and Other segments. The company's products pipeline includes Budesolv for the treatment of allergic rhinitis; Tacrosolv, which is in Phase II clinical trial for inflammatory eye diseases; and Inhaleen for viral infection of the upper and lower respiratory tract. It also provides Solv4U which offers formulation development and biopharmaceutical testing services. It has a technology partnership with SPH Sine Pharmaceutical Laboratories Co. Ltd. The company was formerly known as Marinomed Biotechnologie GmbH and changed its name to Marinomed Biotech AG in June 2017. Marinomed Biotech AG was incorporated in 2006 and is headquartered in Korneuburg, Austria.
Show more...
CEO
Mr. Andreas Grassauer Ph.D.
Employees
33
Country
Other
ISIN
ATMARINOMED6
Listings
0 Comments
Share your thoughts
FAQ
What is Marinomed Biotech stock price today?▼
The current price of 93Z.MU is €13.6 EUR — it has increased by +0.74% in the past 24 hours. Watch Marinomed Biotech stock price performance more closely on the chart.
What is Marinomed Biotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Marinomed Biotech stocks are traded under the ticker 93Z.MU.
Is Marinomed Biotech stock price growing?▼
93Z.MU stock has risen by +0% compared to the previous week, the month change is a -5.23% fall, over the last year Marinomed Biotech has showed a +11.41% increase.
When is the next Marinomed Biotech earnings date?▼
Marinomed Biotech is going to release the next earnings report on September 16, 2026.
How many employees does Marinomed Biotech have?▼
As of April 29, 2026, the company has 33 employees.
In which sector is Marinomed Biotech located?▼
Marinomed Biotech operates in the Health & Wellness sector.
When did Marinomed Biotech complete a stock split?▼
Marinomed Biotech has not had any recent stock splits.
Where is Marinomed Biotech headquartered?▼
Marinomed Biotech is headquartered in Korneuburg, Other.